About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Report banner
Home
Industries
Healthcare
Medical Device

report thumbnailCompanion Diagnostics Market

Companion Diagnostics Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Companion Diagnostics Market by Technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, Others), by Indication (Cancer, Neurological Diseases, Infectious Diseases, Others), by End-user (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), by By Geography (North America), by Europe (Germany, U.K., France, Italy, Spain, Scandinavia, Rest of Europe), by Asia Pacific (China, Japan, India, Australia, Southeast Asia, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Rest of Latin America), by Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa) Forecast 2026-2034

Jan 9 2025

Base Year: 2025

135 Pages

Main Logo

Companion Diagnostics Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Main Logo

Companion Diagnostics Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities


Related Reports


report thumbnailPoint-of-Care Diagnostics Market

Point-of-Care Diagnostics Market 7.9 CAGR Growth Outlook 2025-2033

report thumbnailRapid Diagnostics Market

Rapid Diagnostics Market 2025 to Grow at 8.1 CAGR with XX USD Billion Market Size: Analysis and Forecasts 2033

report thumbnailCompanion Diagnostics

Companion Diagnostics Soars to 9403.6 million , witnessing a CAGR of XX during the forecast period 2025-2033

report thumbnailDigital Companion Diagnostics

Digital Companion Diagnostics Strategic Roadmap: Analysis and Forecasts 2025-2033

report thumbnailCompanion Diagnostic

Companion Diagnostic 2025 to Grow at 19.4 CAGR with 9075.3 million Market Size: Analysis and Forecasts 2033

Business Address

Head Office

Ansec House 3 rd floor Tank Road, Yerwada, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

[email protected]

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2026 PRDUA Research & Media Private Limited, All rights reserved

Privacy Policy
Terms and Conditions
FAQ

+1 2315155523

[email protected]

  • Home
  • About Us
  • Industries
    • Chemicals & Materials
    • Automotive & Transportation
    • Machinery & Equipment
    • Agriculture
    • COVID-19 Analysis
    • Energy & Power
    • Consumer Goods
    • Packaging
    • Food & Beverages
    • Semiconductor & Electronics
    • Information & Technology
    • Healthcare
    • Aerospace & Defense
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Chemicals & Materials
    • Automotive & Transportation
    • Machinery & Equipment
    • Agriculture
    • COVID-19 Analysis
    • Energy & Power
    • Consumer Goods
    • Packaging
    • Food & Beverages
    • Semiconductor & Electronics
    • Information & Technology
    • Healthcare
    • Aerospace & Defense
  • Services
  • Contact
[email protected]
Get Free Sample
Hover animation image
Pre Order Enquiry Request discount

Pricing

$6850
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$4850
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
BUY NOW

Related Reports

Point-of-Care Diagnostics Market 7.9 CAGR Growth Outlook 2025-2033

Point-of-Care Diagnostics Market 7.9 CAGR Growth Outlook 2025-2033

Rapid Diagnostics Market 2025 to Grow at 8.1 CAGR with XX USD Billion Market Size: Analysis and Forecasts 2033

Rapid Diagnostics Market 2025 to Grow at 8.1 CAGR with XX USD Billion Market Size: Analysis and Forecasts 2033

Companion Diagnostics Soars to 9403.6 million , witnessing a CAGR of XX during the forecast period 2025-2033

Companion Diagnostics Soars to 9403.6 million , witnessing a CAGR of XX during the forecast period 2025-2033

Digital Companion Diagnostics Strategic Roadmap: Analysis and Forecasts 2025-2033

Digital Companion Diagnostics Strategic Roadmap: Analysis and Forecasts 2025-2033

Companion Diagnostic 2025 to Grow at 19.4 CAGR with 9075.3 million Market Size: Analysis and Forecasts 2033

Companion Diagnostic 2025 to Grow at 19.4 CAGR with 9075.3 million Market Size: Analysis and Forecasts 2033

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

Key Insights

The Companion Diagnostics Marketsize was valued at USD 6.80 USD billion in 2023 and is projected to reach USD 21.03 USD billion by 2032, exhibiting a CAGR of 17.5 % during the forecast period.Companion diagnostics stand for highly specialized tests or assays intended to be used simultaneously with some rather specific therapies as a tool to personalize treatment for patients based on their specific genetic or molecular attributes. These diagnostics are aimed at molecular characterizations of the patient sample from the point of view of their response to a particular drug and the risk of getting the side effects of the same. The major characteristic of companion diagnostics is their capability of stratifying patients into subgroups that might have different biomarker profile, thereby enabling the healthcare provider to personalize the treatment plan. Such assays are usually generated as tools for the corresponding targeted therapies; therefore, accuracy and reliability are guaranteed. Companion diagnostics has a considerable impact in not one way but several ways. First, they reduce the treatment outcomes by helping doctors choose the therapies that have a higher efficiency rate on specific patients' group. This individualized method consequently drastically reduces the risks of inappropriate treatments and decreases the likelihood of adverse drug reactions enabling better patient outcomes and improved safety. In addition, companion diagnostics increase overall value by helping to optimize resource use which includes reducing unwanted treatments and procedures aside from simplifying the drug development process. Moreover, they are extremely important in making sure that precision medicine programs are realized by ensuring accurate targeted interventions, which are based on a genetic and molecular level. Briefly put, companion diagnostics are important perspective in modern age of personalized medicine that deliver progress in diagnosis making, patients outcomes, health care system provision, and personalized medicine methods.

Companion Diagnostics Market Research Report - Market Overview and Key Insights

Companion Diagnostics Market Market Size (In Million)

20.0M
15.0M
10.0M
5.0M
0
11.30 M
2021
12.50 M
2022
13.80 M
2023
15.20 M
2024
16.70 M
2025
Main Logo

Companion Diagnostics Trends

  • Rising adoption of precision medicine and targeted therapies
  • Integration of AI and machine learning for improved diagnostics
  • Development of multiplex companion diagnostics tests for comprehensive analysis
  • Increasing collaboration between pharmaceutical companies and diagnostics providers
Companion Diagnostics Market Market Size and Forecast (2024-2030)

Companion Diagnostics Market Company Market Share

Loading chart...
Main Logo

Driving Forces: What's Propelling the Companion Diagnostics Market

  • Growing demand for personalized healthcare solutions
  • Rapid advancements in genomics, including next-generation sequencing (NGS) technologies
  • Increasing FDA approvals for companion diagnostics tests, expanding their role in clinical decision-making
  • Technological breakthroughs in biomarker discovery and analysis techniques, enabling more precise and targeted therapies

Challenges and Restraints in Companion Diagnostics Market

  • High development and commercialization costs associated with companion diagnostics, posing barriers for market entry
  • Limited reimbursement policies for companion diagnostics, impacting patient access and market growth
  • Concerns over data privacy and security in the handling of genetic information
  • Regulatory complexities and stringent guidelines governing the development and use of companion diagnostics

Emerging Trends in Companion Diagnostics

  • Liquid biopsy-based companion diagnostics for non-invasive testing
  • Development of companion diagnostics for rare diseases and genetic disorders
  • AI-powered data analytics for personalized treatment planning
  • Point-of-care companion diagnostics for rapid and accessible testing

Growth Catalysts in Companion Diagnostics Industry

  • Government initiatives and research funding for precision medicine, driving innovation and market expansion
  • Strategic alliances between pharmaceutical and diagnostics companies, fostering cross-disciplinary collaboration
  • Technological advancements reducing costs and improving the accuracy and accessibility of companion diagnostics
  • Increased awareness and growing demand for personalized healthcare, creating a favorable market environment

Market Segmentation: Companion Diagnostics Analysis

Technology:

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In-situ Hybridization (ISH)
  • Next Generation Gene Sequencing (NGS)

Indication:

  • Cancer
  • Neurological Diseases
  • Infectious Diseases

End-user:

  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • Contract Research Organizations

Leading Players in the Companion Diagnostics Market

  • Abbott (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, Inc. (United States)
  • Illumina, Inc. (United States)
  • Guardant Health (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • BIOMERIEUX (France)
  • QIAGEN (Germany)
  • Myriad Genetics, Inc. (United States)

Significant developments in Companion Diagnostics Sector

  • FDA approval of new companion diagnostics tests
  • Strategic acquisitions and collaborations among industry players
  • Launch of innovative technologies and platforms
  • Investment in research and development for next-generation companion diagnostics

Comprehensive Coverage Companion Diagnostics Market Report

Stay ahead of the curve in the rapidly evolving companion diagnostics industry with our comprehensive market report. Delve into a wealth of insights, including:

  • Market Size and Growth Potential: Gain a clear understanding of the market's current size and projected growth trajectory.
  • Market Segmentation: Explore detailed segmentation by product type, application, and geographic region to identify key growth areas.
  • Key Trends and Drivers: Stay abreast of the latest industry trends, advancements, and factors driving market growth.
  • Company Profiles: Get an in-depth analysis of major players in the market, their strategies, and market share.
  • Competitive Landscape: Assess the competitive landscape, including market share analysis, competitive dynamics, and industry challenges.

Download the full market research report for a comprehensive understanding of the companion diagnostics market and gain valuable insights to make informed decisions and capitalize on growth opportunities.

Regional Insight

  • North America (U.S., Canada) - Retains the dominant market share due to advanced healthcare systems and high prevalence of chronic diseases
  • Europe (Germany, France, U.K.) - Growing adoption of precision medicine and increasing government support drive market expansion
  • Asia-Pacific (China, Japan, India) - Rapidly expanding market with increasing healthcare investments and rising awareness about companion diagnostics
  • Rest of the World (Latin America, Middle East, Africa) - Emerging markets with significant potential and untapped opportunities
Companion Diagnostics Market Market Share by Region - Global Geographic Distribution

Companion Diagnostics Market Regional Market Share

Loading chart...
Main Logo

DROCT

D: Drivers - Rising prevalence of chronic diseases, technological advancements, increasing government support 

R: Restraints - High cost, limited reimbursement, data privacy concerns 

O: Opportunities - Liquid biopsy, AI-powered diagnostics, personalized healthcare 

C: Challenges - Regulatory barriers, reimbursement policies, market competition 

T: Threats - Changing healthcare landscape, evolving regulatory framework

Pricing Analysis

The pricing of companion diagnostics tests varies depending on several factors, including technology, indication, and geographical location. Typically, multiplex tests are more expensive than single-gene tests. The cost of companion diagnostics can range from a few hundred dollars to several thousand dollars.

Import And Export Analysis

The U.S. is a major exporter of companion diagnostics products, while China and India are significant importers. The increasing demand for companion diagnostics in developing countries is driving the import market.

Segmentation

By Type:

  • In Vitro Diagnostics (IVD)
  • Next Generation Sequencing (NGS)

By Application:

  • Oncology
  • Infectious Diseases
  • Neurological Diseases

By End-User:

  • Hospitals and Laboratories
  • Pharmaceutical Companies
  • Research Institutes

Patent/Trademark Analysis

Several patents and trademarks related to companion diagnostics have been filed and granted globally. These patents cover various aspects of companion diagnostics, including novel technologies, biomarkers, and therapeutic applications.

Geographic Coverage of Companion Diagnostics Market

Higher Coverage
Lower Coverage
No Coverage

Companion Diagnostics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 17.5% from 2020-2034
Segmentation
    • By Technology
      • Polymerase Chain Reaction
      • Immunohistochemistry
      • In-situ Hybridization
      • Next Generation Gene Sequencing
      • Others
    • By Indication
      • Cancer
      • Neurological Diseases
      • Infectious Diseases
      • Others
    • By End-user
      • Pharmaceutical & Biopharmaceutical Companies
      • Reference Laboratories
      • Contract Research Organizations
      • Others
  • By Geography
    • By Geography
      • North America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Scandinavia
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Increasing Prevalence of Cancer to Augment Market Growth
      • 3.3. Market Restrains
        • 3.3.1. Incompetent Reimbursement Scenario and Stringent Regulatory Framework to Restrict Market Growth
      • 3.4. Market Trends
        • 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Companion Diagnostics Market Analysis, Insights and Forecast, 2020-2032
    • 5.1. Market Analysis, Insights and Forecast - by Technology
      • 5.1.1. Polymerase Chain Reaction
      • 5.1.2. Immunohistochemistry
      • 5.1.3. In-situ Hybridization
      • 5.1.4. Next Generation Gene Sequencing
      • 5.1.5. Others
    • 5.2. Market Analysis, Insights and Forecast - by Indication
      • 5.2.1. Cancer
      • 5.2.2. Neurological Diseases
      • 5.2.3. Infectious Diseases
      • 5.2.4. Others
    • 5.3. Market Analysis, Insights and Forecast - by End-user
      • 5.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 5.3.2. Reference Laboratories
      • 5.3.3. Contract Research Organizations
      • 5.3.4. Others
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. By Geography
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. Middle East & Africa
  6. 6. By Geography Companion Diagnostics Market Analysis, Insights and Forecast, 2020-2032
    • 6.1. Market Analysis, Insights and Forecast - by Technology
      • 6.1.1. Polymerase Chain Reaction
      • 6.1.2. Immunohistochemistry
      • 6.1.3. In-situ Hybridization
      • 6.1.4. Next Generation Gene Sequencing
      • 6.1.5. Others
    • 6.2. Market Analysis, Insights and Forecast - by Indication
      • 6.2.1. Cancer
      • 6.2.2. Neurological Diseases
      • 6.2.3. Infectious Diseases
      • 6.2.4. Others
    • 6.3. Market Analysis, Insights and Forecast - by End-user
      • 6.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 6.3.2. Reference Laboratories
      • 6.3.3. Contract Research Organizations
      • 6.3.4. Others
  7. 7. Europe Companion Diagnostics Market Analysis, Insights and Forecast, 2020-2032
    • 7.1. Market Analysis, Insights and Forecast - by Technology
      • 7.1.1. Polymerase Chain Reaction
      • 7.1.2. Immunohistochemistry
      • 7.1.3. In-situ Hybridization
      • 7.1.4. Next Generation Gene Sequencing
      • 7.1.5. Others
    • 7.2. Market Analysis, Insights and Forecast - by Indication
      • 7.2.1. Cancer
      • 7.2.2. Neurological Diseases
      • 7.2.3. Infectious Diseases
      • 7.2.4. Others
    • 7.3. Market Analysis, Insights and Forecast - by End-user
      • 7.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 7.3.2. Reference Laboratories
      • 7.3.3. Contract Research Organizations
      • 7.3.4. Others
  8. 8. Asia Pacific Companion Diagnostics Market Analysis, Insights and Forecast, 2020-2032
    • 8.1. Market Analysis, Insights and Forecast - by Technology
      • 8.1.1. Polymerase Chain Reaction
      • 8.1.2. Immunohistochemistry
      • 8.1.3. In-situ Hybridization
      • 8.1.4. Next Generation Gene Sequencing
      • 8.1.5. Others
    • 8.2. Market Analysis, Insights and Forecast - by Indication
      • 8.2.1. Cancer
      • 8.2.2. Neurological Diseases
      • 8.2.3. Infectious Diseases
      • 8.2.4. Others
    • 8.3. Market Analysis, Insights and Forecast - by End-user
      • 8.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 8.3.2. Reference Laboratories
      • 8.3.3. Contract Research Organizations
      • 8.3.4. Others
  9. 9. Latin America Companion Diagnostics Market Analysis, Insights and Forecast, 2020-2032
    • 9.1. Market Analysis, Insights and Forecast - by Technology
      • 9.1.1. Polymerase Chain Reaction
      • 9.1.2. Immunohistochemistry
      • 9.1.3. In-situ Hybridization
      • 9.1.4. Next Generation Gene Sequencing
      • 9.1.5. Others
    • 9.2. Market Analysis, Insights and Forecast - by Indication
      • 9.2.1. Cancer
      • 9.2.2. Neurological Diseases
      • 9.2.3. Infectious Diseases
      • 9.2.4. Others
    • 9.3. Market Analysis, Insights and Forecast - by End-user
      • 9.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 9.3.2. Reference Laboratories
      • 9.3.3. Contract Research Organizations
      • 9.3.4. Others
  10. 10. Middle East & Africa Companion Diagnostics Market Analysis, Insights and Forecast, 2020-2032
    • 10.1. Market Analysis, Insights and Forecast - by Technology
      • 10.1.1. Polymerase Chain Reaction
      • 10.1.2. Immunohistochemistry
      • 10.1.3. In-situ Hybridization
      • 10.1.4. Next Generation Gene Sequencing
      • 10.1.5. Others
    • 10.2. Market Analysis, Insights and Forecast - by Indication
      • 10.2.1. Cancer
      • 10.2.2. Neurological Diseases
      • 10.2.3. Infectious Diseases
      • 10.2.4. Others
    • 10.3. Market Analysis, Insights and Forecast - by End-user
      • 10.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 10.3.2. Reference Laboratories
      • 10.3.3. Contract Research Organizations
      • 10.3.4. Others
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2025
      • 11.2. Company Profiles
        • 11.2.1 Abbott (U.S.)
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 F. Hoffmann-La Roche Ltd. (Switzerland)
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Agilent Technologies Inc. (U.S.)
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Illumina Inc. (U.S.)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Guardant Health (U.S.)
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Thermo Fisher Scientific Inc. (U.S.)
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 BIOMERIEUX (France)
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 QIAGEN (Germany)
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Myriad Genetics Inc. (U.S.)
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)

List of Figures

  1. Figure 1: Global Companion Diagnostics Market Revenue Breakdown (USD billion, %) by Region 2025 & 2033
  2. Figure 2: Global Companion Diagnostics Market Volume Breakdown (1,000 Units, %) by Region 2025 & 2033
  3. Figure 3: By Geography Companion Diagnostics Market Revenue (USD billion), by Technology 2025 & 2033
  4. Figure 4: By Geography Companion Diagnostics Market Volume (1,000 Units), by Technology 2025 & 2033
  5. Figure 5: By Geography Companion Diagnostics Market Revenue Share (%), by Technology 2025 & 2033
  6. Figure 6: By Geography Companion Diagnostics Market Volume Share (%), by Technology 2025 & 2033
  7. Figure 7: By Geography Companion Diagnostics Market Revenue (USD billion), by Indication 2025 & 2033
  8. Figure 8: By Geography Companion Diagnostics Market Volume (1,000 Units), by Indication 2025 & 2033
  9. Figure 9: By Geography Companion Diagnostics Market Revenue Share (%), by Indication 2025 & 2033
  10. Figure 10: By Geography Companion Diagnostics Market Volume Share (%), by Indication 2025 & 2033
  11. Figure 11: By Geography Companion Diagnostics Market Revenue (USD billion), by End-user 2025 & 2033
  12. Figure 12: By Geography Companion Diagnostics Market Volume (1,000 Units), by End-user 2025 & 2033
  13. Figure 13: By Geography Companion Diagnostics Market Revenue Share (%), by End-user 2025 & 2033
  14. Figure 14: By Geography Companion Diagnostics Market Volume Share (%), by End-user 2025 & 2033
  15. Figure 15: By Geography Companion Diagnostics Market Revenue (USD billion), by Country 2025 & 2033
  16. Figure 16: By Geography Companion Diagnostics Market Volume (1,000 Units), by Country 2025 & 2033
  17. Figure 17: By Geography Companion Diagnostics Market Revenue Share (%), by Country 2025 & 2033
  18. Figure 18: By Geography Companion Diagnostics Market Volume Share (%), by Country 2025 & 2033
  19. Figure 19: Europe Companion Diagnostics Market Revenue (USD billion), by Technology 2025 & 2033
  20. Figure 20: Europe Companion Diagnostics Market Volume (1,000 Units), by Technology 2025 & 2033
  21. Figure 21: Europe Companion Diagnostics Market Revenue Share (%), by Technology 2025 & 2033
  22. Figure 22: Europe Companion Diagnostics Market Volume Share (%), by Technology 2025 & 2033
  23. Figure 23: Europe Companion Diagnostics Market Revenue (USD billion), by Indication 2025 & 2033
  24. Figure 24: Europe Companion Diagnostics Market Volume (1,000 Units), by Indication 2025 & 2033
  25. Figure 25: Europe Companion Diagnostics Market Revenue Share (%), by Indication 2025 & 2033
  26. Figure 26: Europe Companion Diagnostics Market Volume Share (%), by Indication 2025 & 2033
  27. Figure 27: Europe Companion Diagnostics Market Revenue (USD billion), by End-user 2025 & 2033
  28. Figure 28: Europe Companion Diagnostics Market Volume (1,000 Units), by End-user 2025 & 2033
  29. Figure 29: Europe Companion Diagnostics Market Revenue Share (%), by End-user 2025 & 2033
  30. Figure 30: Europe Companion Diagnostics Market Volume Share (%), by End-user 2025 & 2033
  31. Figure 31: Europe Companion Diagnostics Market Revenue (USD billion), by Country 2025 & 2033
  32. Figure 32: Europe Companion Diagnostics Market Volume (1,000 Units), by Country 2025 & 2033
  33. Figure 33: Europe Companion Diagnostics Market Revenue Share (%), by Country 2025 & 2033
  34. Figure 34: Europe Companion Diagnostics Market Volume Share (%), by Country 2025 & 2033
  35. Figure 35: Asia Pacific Companion Diagnostics Market Revenue (USD billion), by Technology 2025 & 2033
  36. Figure 36: Asia Pacific Companion Diagnostics Market Volume (1,000 Units), by Technology 2025 & 2033
  37. Figure 37: Asia Pacific Companion Diagnostics Market Revenue Share (%), by Technology 2025 & 2033
  38. Figure 38: Asia Pacific Companion Diagnostics Market Volume Share (%), by Technology 2025 & 2033
  39. Figure 39: Asia Pacific Companion Diagnostics Market Revenue (USD billion), by Indication 2025 & 2033
  40. Figure 40: Asia Pacific Companion Diagnostics Market Volume (1,000 Units), by Indication 2025 & 2033
  41. Figure 41: Asia Pacific Companion Diagnostics Market Revenue Share (%), by Indication 2025 & 2033
  42. Figure 42: Asia Pacific Companion Diagnostics Market Volume Share (%), by Indication 2025 & 2033
  43. Figure 43: Asia Pacific Companion Diagnostics Market Revenue (USD billion), by End-user 2025 & 2033
  44. Figure 44: Asia Pacific Companion Diagnostics Market Volume (1,000 Units), by End-user 2025 & 2033
  45. Figure 45: Asia Pacific Companion Diagnostics Market Revenue Share (%), by End-user 2025 & 2033
  46. Figure 46: Asia Pacific Companion Diagnostics Market Volume Share (%), by End-user 2025 & 2033
  47. Figure 47: Asia Pacific Companion Diagnostics Market Revenue (USD billion), by Country 2025 & 2033
  48. Figure 48: Asia Pacific Companion Diagnostics Market Volume (1,000 Units), by Country 2025 & 2033
  49. Figure 49: Asia Pacific Companion Diagnostics Market Revenue Share (%), by Country 2025 & 2033
  50. Figure 50: Asia Pacific Companion Diagnostics Market Volume Share (%), by Country 2025 & 2033
  51. Figure 51: Latin America Companion Diagnostics Market Revenue (USD billion), by Technology 2025 & 2033
  52. Figure 52: Latin America Companion Diagnostics Market Volume (1,000 Units), by Technology 2025 & 2033
  53. Figure 53: Latin America Companion Diagnostics Market Revenue Share (%), by Technology 2025 & 2033
  54. Figure 54: Latin America Companion Diagnostics Market Volume Share (%), by Technology 2025 & 2033
  55. Figure 55: Latin America Companion Diagnostics Market Revenue (USD billion), by Indication 2025 & 2033
  56. Figure 56: Latin America Companion Diagnostics Market Volume (1,000 Units), by Indication 2025 & 2033
  57. Figure 57: Latin America Companion Diagnostics Market Revenue Share (%), by Indication 2025 & 2033
  58. Figure 58: Latin America Companion Diagnostics Market Volume Share (%), by Indication 2025 & 2033
  59. Figure 59: Latin America Companion Diagnostics Market Revenue (USD billion), by End-user 2025 & 2033
  60. Figure 60: Latin America Companion Diagnostics Market Volume (1,000 Units), by End-user 2025 & 2033
  61. Figure 61: Latin America Companion Diagnostics Market Revenue Share (%), by End-user 2025 & 2033
  62. Figure 62: Latin America Companion Diagnostics Market Volume Share (%), by End-user 2025 & 2033
  63. Figure 63: Latin America Companion Diagnostics Market Revenue (USD billion), by Country 2025 & 2033
  64. Figure 64: Latin America Companion Diagnostics Market Volume (1,000 Units), by Country 2025 & 2033
  65. Figure 65: Latin America Companion Diagnostics Market Revenue Share (%), by Country 2025 & 2033
  66. Figure 66: Latin America Companion Diagnostics Market Volume Share (%), by Country 2025 & 2033
  67. Figure 67: Middle East & Africa Companion Diagnostics Market Revenue (USD billion), by Technology 2025 & 2033
  68. Figure 68: Middle East & Africa Companion Diagnostics Market Volume (1,000 Units), by Technology 2025 & 2033
  69. Figure 69: Middle East & Africa Companion Diagnostics Market Revenue Share (%), by Technology 2025 & 2033
  70. Figure 70: Middle East & Africa Companion Diagnostics Market Volume Share (%), by Technology 2025 & 2033
  71. Figure 71: Middle East & Africa Companion Diagnostics Market Revenue (USD billion), by Indication 2025 & 2033
  72. Figure 72: Middle East & Africa Companion Diagnostics Market Volume (1,000 Units), by Indication 2025 & 2033
  73. Figure 73: Middle East & Africa Companion Diagnostics Market Revenue Share (%), by Indication 2025 & 2033
  74. Figure 74: Middle East & Africa Companion Diagnostics Market Volume Share (%), by Indication 2025 & 2033
  75. Figure 75: Middle East & Africa Companion Diagnostics Market Revenue (USD billion), by End-user 2025 & 2033
  76. Figure 76: Middle East & Africa Companion Diagnostics Market Volume (1,000 Units), by End-user 2025 & 2033
  77. Figure 77: Middle East & Africa Companion Diagnostics Market Revenue Share (%), by End-user 2025 & 2033
  78. Figure 78: Middle East & Africa Companion Diagnostics Market Volume Share (%), by End-user 2025 & 2033
  79. Figure 79: Middle East & Africa Companion Diagnostics Market Revenue (USD billion), by Country 2025 & 2033
  80. Figure 80: Middle East & Africa Companion Diagnostics Market Volume (1,000 Units), by Country 2025 & 2033
  81. Figure 81: Middle East & Africa Companion Diagnostics Market Revenue Share (%), by Country 2025 & 2033
  82. Figure 82: Middle East & Africa Companion Diagnostics Market Volume Share (%), by Country 2025 & 2033

List of Tables

  1. Table 1: Global Companion Diagnostics Market Revenue USD billion Forecast, by Technology 2020 & 2033
  2. Table 2: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Technology 2020 & 2033
  3. Table 3: Global Companion Diagnostics Market Revenue USD billion Forecast, by Indication 2020 & 2033
  4. Table 4: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Indication 2020 & 2033
  5. Table 5: Global Companion Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
  6. Table 6: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by End-user 2020 & 2033
  7. Table 7: Global Companion Diagnostics Market Revenue USD billion Forecast, by Region 2020 & 2033
  8. Table 8: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Region 2020 & 2033
  9. Table 9: Global Companion Diagnostics Market Revenue USD billion Forecast, by Technology 2020 & 2033
  10. Table 10: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Technology 2020 & 2033
  11. Table 11: Global Companion Diagnostics Market Revenue USD billion Forecast, by Indication 2020 & 2033
  12. Table 12: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Indication 2020 & 2033
  13. Table 13: Global Companion Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
  14. Table 14: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by End-user 2020 & 2033
  15. Table 15: Global Companion Diagnostics Market Revenue USD billion Forecast, by Country 2020 & 2033
  16. Table 16: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Country 2020 & 2033
  17. Table 17: North America Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  18. Table 18: North America Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  19. Table 19: Global Companion Diagnostics Market Revenue USD billion Forecast, by Technology 2020 & 2033
  20. Table 20: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Technology 2020 & 2033
  21. Table 21: Global Companion Diagnostics Market Revenue USD billion Forecast, by Indication 2020 & 2033
  22. Table 22: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Indication 2020 & 2033
  23. Table 23: Global Companion Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
  24. Table 24: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by End-user 2020 & 2033
  25. Table 25: Global Companion Diagnostics Market Revenue USD billion Forecast, by Country 2020 & 2033
  26. Table 26: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Country 2020 & 2033
  27. Table 27: Germany Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  28. Table 28: Germany Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  29. Table 29: U.K. Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  30. Table 30: U.K. Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  31. Table 31: France Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  32. Table 32: France Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  33. Table 33: Italy Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  34. Table 34: Italy Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  35. Table 35: Spain Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  36. Table 36: Spain Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  37. Table 37: Scandinavia Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  38. Table 38: Scandinavia Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  39. Table 39: Rest of Europe Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  40. Table 40: Rest of Europe Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  41. Table 41: Global Companion Diagnostics Market Revenue USD billion Forecast, by Technology 2020 & 2033
  42. Table 42: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Technology 2020 & 2033
  43. Table 43: Global Companion Diagnostics Market Revenue USD billion Forecast, by Indication 2020 & 2033
  44. Table 44: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Indication 2020 & 2033
  45. Table 45: Global Companion Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
  46. Table 46: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by End-user 2020 & 2033
  47. Table 47: Global Companion Diagnostics Market Revenue USD billion Forecast, by Country 2020 & 2033
  48. Table 48: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Country 2020 & 2033
  49. Table 49: China Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  50. Table 50: China Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  51. Table 51: Japan Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  52. Table 52: Japan Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  53. Table 53: India Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  54. Table 54: India Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  55. Table 55: Australia Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  56. Table 56: Australia Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  57. Table 57: Southeast Asia Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  58. Table 58: Southeast Asia Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  59. Table 59: Rest of Asia Pacific Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  60. Table 60: Rest of Asia Pacific Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  61. Table 61: Global Companion Diagnostics Market Revenue USD billion Forecast, by Technology 2020 & 2033
  62. Table 62: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Technology 2020 & 2033
  63. Table 63: Global Companion Diagnostics Market Revenue USD billion Forecast, by Indication 2020 & 2033
  64. Table 64: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Indication 2020 & 2033
  65. Table 65: Global Companion Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
  66. Table 66: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by End-user 2020 & 2033
  67. Table 67: Global Companion Diagnostics Market Revenue USD billion Forecast, by Country 2020 & 2033
  68. Table 68: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Country 2020 & 2033
  69. Table 69: Brazil Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  70. Table 70: Brazil Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  71. Table 71: Mexico Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  72. Table 72: Mexico Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  73. Table 73: Rest of Latin America Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  74. Table 74: Rest of Latin America Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  75. Table 75: Global Companion Diagnostics Market Revenue USD billion Forecast, by Technology 2020 & 2033
  76. Table 76: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Technology 2020 & 2033
  77. Table 77: Global Companion Diagnostics Market Revenue USD billion Forecast, by Indication 2020 & 2033
  78. Table 78: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Indication 2020 & 2033
  79. Table 79: Global Companion Diagnostics Market Revenue USD billion Forecast, by End-user 2020 & 2033
  80. Table 80: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by End-user 2020 & 2033
  81. Table 81: Global Companion Diagnostics Market Revenue USD billion Forecast, by Country 2020 & 2033
  82. Table 82: Global Companion Diagnostics Market Volume 1,000 Units Forecast, by Country 2020 & 2033
  83. Table 83: GCC Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  84. Table 84: GCC Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  85. Table 85: South Africa Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  86. Table 86: South Africa Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033
  87. Table 87: Rest of Middle East & Africa Companion Diagnostics Market Revenue (USD billion) Forecast, by Application 2020 & 2033
  88. Table 88: Rest of Middle East & Africa Companion Diagnostics Market Volume (1,000 Units) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step Chart
Bar Chart
Method Chart

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Approach Chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
Analyst Chart

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Companion Diagnostics Market?

The projected CAGR is approximately 17.5%.

2. Which companies are prominent players in the Companion Diagnostics Market?

Key companies in the market include Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), Guardant Health (U.S.), Thermo Fisher Scientific Inc. (U.S.), BIOMERIEUX (France), QIAGEN (Germany), Myriad Genetics, Inc. (U.S.).

3. What are the main segments of the Companion Diagnostics Market?

The market segments include Technology, Indication, End-user.

4. Can you provide details about the market size?

The market size is estimated to be USD 6.80 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Increasing Prevalence of Cancer to Augment Market Growth.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Incompetent Reimbursement Scenario and Stringent Regulatory Framework to Restrict Market Growth.

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion and volume, measured in 1,000 Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Companion Diagnostics Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Companion Diagnostics Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Companion Diagnostics Market?

To stay informed about further developments, trends, and reports in the Companion Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.